Virpax Pharmaceuticals In...
0.35
0.00 (0.29%)
At close: Jan 15, 2025, 3:59 PM
0.33
-2.98%
After-hours Jan 15, 2025, 04:35 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue n/a n/a n/a n/a n/a n/a
Cost of Revenue n/a n/a n/a n/a n/a n/a
Gross Profit n/a n/a n/a n/a n/a n/a
Operating Income -15.69M -21.85M -12.03M -4.20M -3.18M -2.63M
Interest Income n/a n/a 92.82 147.93 124.64 n/a
Pretax Income -15.19M -21.65M -12.06M -4.34M -3.31M -2.64M
Net Income -15.19M -21.46M -12.15M -4.49M -3.43M -2.64M
Selling & General & Admin 7.82M 11.08M 7.19M 2.90M 2.56M 1.48M
Research & Development 5.12M 10.76M 4.84M 1.29M 622.74K 1.14M
Other Expenses 2.75M 194.41K 62.26K 4.00K n/a n/a
Operating Expenses 15.69M 21.85M 12.03M 4.20M 3.18M 2.63M
Interest Expense n/a n/a 92.82K 147.93K 124.64K 14.98K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a
Cost & Expenses 15.69M 21.85M 12.03M 4.20M 3.18M 2.63M
Income Tax n/a -194.41K 92.82K 147.93K 124.64K -161.14K
Shares Outstanding (Basic) 1.17M 1.17M 1.17M 494.51K 521.51K 4.95M
Shares Outstanding (Diluted) 1.17M 1.17M 1.17M 494.51K 521.51K 4.95M
EPS (Basic) -12.97 -18.32 -10.37 -9.07 -6.58 -0.53
EPS (Diluted) -12.97 -18.32 -10.37 -9.07 -6.58 -0.53
EBITDA -15.19M n/a n/a -4.19M n/a n/a
Depreciation & Amortization 500.28K 18.35M 12.03M 4.20M 3.18M 2.63M

Create Price Alert on VRPX

Your price alert will notify you when the stock price is above 0.35.

Add to Watchlist